Comparative biodistribution analysis of umbilical cord mesenchymal stromal cells via different administration routes in rabbit models
References
- M. F. Pittenger, D. E. Discher, B. M. Péault, D. G. Phinney, J. M. Hare and A. I. Caplan, Mesenchymal stem cell perspective: Cell biology to clinical progress, npj Regen. Med. 4(1) (2019) Article ID 22 (15 pages); https://doi.org/10.1038/s41536-019-0083-6
- P. Wanyan, X. Wang, N. Li, Y. Huang, Y. She and L. Zhang, Mesenchymal stem cells therapy for acute kidney injury: A systematic review with meta-analysis based on rat model, Front. Pharmacol. 14 (2023) Article ID 1099056 (14 pages); https://doi.org/10.3389/fphar.2023.1099056
- X. Han, J. Wang, R. Li, M. Huang, G. Yue, L. Guan, Y. Deng, W. Cai and J. Xu, Placental mesenchymal stem cells alleviate podocyte injury in diabetic kidney disease by modulating mitophagy via the SIRT1-PGC-1alpha-TFAM pathway, Int. J. Molecular Sci. 24(5) (2023) Article ID 22 (19 pages); https://doi.org/10.3390/ijms24054696
- S. Afra and M. M. Matin, Potential of mesenchymal stem cells for bioengineered blood vessels in comparison with other eligible cell sources, Cell Tissue Res. 380 (2020) 1–13; https://doi.org/10.1007/s00441-019-03161-0
- Z. W. Htay, C. F. S. Ng, Y. Kim, Y.-H. Lim, M. Iwagami and M. Hashizume, Associations between short-term exposure to ambient temperature and renal disease mortality in Japan during 1979–2019: A time-stratified case-crossover analysis, Environmental Epidemiol. 8(1) (2024) e293 (7 pages); https://doi.org/10.1097/ee9.0000000000000293
- K. Iseri, M. Iyoda, H. Ohtaki, K. Matsumoto, Y. Wada, T. Suzuki, Y. Yamamoto, T. Saito, K. Hihara, S. Tachibana, K. Honda and T. Shibata, Therapeutic effects and mechanism of conditioned media from human mesenchymal stem cells on anti-GBM glomerulonephritis in WKY rats, Am. J. Physiol. Renal Physiol. 310(11) (2016) F1182-91; https://doi.org/10.1152/ajprenal.00165.2016
- R. J. Cheng, A. J. Xiong, Y. H. Li, S. Y. Pan, Q. P. Zhang, Y. Zhao, Y. Liu and T. N. Marion, Mesenchymal stem cells: Allogeneic MSC may be immunosuppressive but autologous MSC are dysfunctional in lupus patients, Front. Cell Dev. Biol. 7 (2019) Article ID 285 (13 pages); https://doi.org/10.3389/fcell.2019.00285
- J. Barbado, S. Tabera, A. Sánchez and J. García-Sancho, Therapeutic potential of allogeneic mesenchymal stromal cells transplantation for lupus nephritis, Lupus 27(13) (2018) 2161–2165; https://doi.org/10.1177/0961203318804922
- H. S. Kim, J. S. Lee, H. K. Lee, E. J. Park, H. W. Jeon, Y. J. Kang, T. Y. Lee, K. S. Kim, S. C. Bae, J. H. Park and S. B. Han, Mesenchymal stem cells ameliorate renal inflammation in adriamycin-induced nephropathy, Immune Netw. 19(5) (2019) e36 (10 pages); https://doi.org/10.4110/in.2019.19.e36
- N. Starc, M. Li, M. Algeri, A. Conforti, L. Tomao, A. Pitisci, F. Emma, G. Montini, P. Messa, F. Locatelli, M. E. Bernardo and M. Vivarelli, Phenotypic and functional characterization of mesenchymal stromal cells isolated from pediatric patients with severe idiopathic nephrotic syndrome, Cytotherapy 20(3) (2018) 322–334; https://doi.org/10.1016/j.jcyt.2017.12.001
- H. H. Chang, S. P. Hsu and C. T. Chien, Intrarenal transplantation of hypoxic preconditioned mesenchymal stem cells improves glomerulonephritis through anti-oxidation, anti-ER stress, anti-inflammation, anti-apoptosis, and anti-autophagy, Antioxidants (Basel) 9(1) (2019); Article ID 2 (17 pages) https://doi.org/10.3390/antiox9010002
- V. A. Varela, E. B. Oliveira-Sales, E. Maquigussa, F. T. Borges, P. P. Gattai, A. D. S. Novaes, C. G. Shimoura, R. R. Campos and M. A. Boim, Treatment with mesenchymal stem cells improves reno-vascular hypertension and preserves the ability of the contralateral kidney to excrete sodium, Kidney Blood Pressure Res. 44(6) (2019) 1404–1415; https://doi.org/10.1159/000503346
- M. Gregorini, R. Maccario, M.A. Avanzini, V. Corradetti, A. Moretta, C. Libetta, P. Esposito, F. Bosio, A. Dal Canton and T. Rampino, Antineutrophil cytoplasmic antibody-associated renal vasculitis treated with autologous mesenchymal stromal cells: evaluation of the contribution of immune-mediated mechanisms, Mayo Clinic Proc. 88(10) (2013) 1174–1179; https://doi.org/10.1016/j.mayocp.2013.06.021
- Y. Shi, J. Xie, M. Yang, J. Ma and H. Ren, Transplantation of umbilical cord mesenchymal stem cells into mice with focal segmental glomerulosclerosis delayed disease manifestation, Ann. Transl. Med. 7(16) (2019) Article ID 3 (9 pages); https://doi.org/10.21037/atm.2019.07.71
- F. Yu, J. Chen, X. Wang, Q. Cai, K. Chen and Y. He, MSC-Derived exosomes prevent peritoneal fibroblast transdifferentiation in peritoneal dialysis-associated peritoneal fibrosis, Nephrol. Dialysis Transplant. 38(Supplement_1) (2023) Article ID 4662 (1 page); https://doi.org/10.1093/ndt/gfad063c_4662
- E. Maličev and K. Jazbec, An overview of mesenchymal stem cell heterogeneity and concentration, Pharmaceuticals 17(3) (2024) Article ID 350 (14 pages); https://doi.org/10.3390/ph17030350
- S. Joshi, S. Allabun, S. Ojo, M. S. Alqahtani, P. K. Shukla, M. Abbas, C. Wechtaisong and H. M. Almohiy, Enhanced drug delivery system using mesenchymal stem cells and membrane-coated nanoparticles, Molecules 28(5) (2023) Article ID 2130 (25 pages); https://doi.org/10.3390/molecules28052130
- C. Qi, H. Shi, M. Fan, W. Chen, H. Yao, C. Jiang, L. Meng, S. Pang and R. Lin, Microvesicles from bone marrow-derived mesenchymal stem cells promote Helicobacter pylori-associated gastric cancer progression by transferring thrombospondin-2, Cell Commun. Signal. 21(1) (2023) Article ID 274 (15 pages); https://doi.org/10.1186/s12964-023-01127-y
- A. F. Wise, T. M. Williams, M. B. Kiewiet, N. L. Payne, C. Siatskas, C. S. Samuel and S. D. Ricardo, Human mesenchymal stem cells alter macrophage phenotype and promote regeneration via homing to the kidney following ischemia-reperfusion injury, Am. J. Physiol. Renal Physiol. 306(10) (2014) F1222-35; https://doi.org/10.1152/ajprenal.00675.2013
- S. Qi and D. Wu, Bone marrow-derived mesenchymal stem cells protect against cisplatin-induced acute kidney injury in rats by inhibiting cell apoptosis, Int. J. Mol. Med. 32(6) (2013) 1262–1272; https://doi.org/10.3892/ijmm.2013.1517
- M. Han, Z. Zhang, Z. Liu, Y. Liu, H. Zhao, B. Wang, C. Zhang, H. Shang, Y. Li and S. Wang, Three-dimensional-cultured MSC-derived exosome with hydrogel for cerebral ischemia repair, Biomaterials Advan. 149 (2023) Article ID 213396; https://doi.org/10.1016/j.bioadv.2023.213396
- C. K. Ward, R. G. Gill, R. S. Liddell and J. E. Davies, Umbilical cord stem cell lysate: a new biologic injectate for the putative treatment of acute temporomandibular joint inflammation, J. Inflamm. Res. 16 (2023) 4287–4300; https://doi.org/10.2147/R.S420741
- S. J. Lee, M. O. Ryu, M. S. Seo, S. B. Park, J. O. Ahn, S. M. Han, K. S. Kang, D. H. Bhang and H. Y. Youn, Mesenchymal stem cells contribute to improvement of renal function in a canine kidney injury model, In vivo 31(6) (2017) 1115–1124; https://doi.org/10.21873/invivo.11177
- J. M. Quimby, T. L. Webb, D. S. Gibbons and S. W. Dow, Evaluation of intrarenal mesenchymal stem cell injection for treatment of chronic kidney disease in cats: A pilot study, J. Feline Med. Surgery 13(6) (2011) 418–426; https://doi.org/10.1016/j.jfms.2011.01.005
- M. Taninokuchi Tomassoni, Y. Zhou, L. Braccischi, F. Modestino, J. Fukuda and C. Mosconi, Trans-arterial stem cell injection (TASI): The role of interventional radiology in regenerative medi cine, J. Clin. Med. 13(3) (2024) Article ID 910 (13 pages); https://doi.org/10.3390/jcm13030910
- S. Levitte, A. Ganguly, S. Frolik, A. A. Guevara-Tique, S. Patel, A. Tadas, O. Klein, D. Shyr, R. Agarwal-Hashmi and L. Beach, Precision delivery of steroids as a rescue therapy for gastrointestinal graft-versus-host disease in pediatric stem cell transplant recipients, J. Clin. Med. 12(13) (2023) Article ID 4229 (6 pages); https://doi.org/10.3390/jcm12134229
- E. Cambria, J. Steiger, J. Günter, A. Bopp, P. Wolint, S. P. Hoerstrup and M. Y. Emmert, Cardiac regenerative medicine: The potential of a new generation of stem cells, Transfusion Med. Hemo-therapy 43(4) (2016) 275–281; https://doi.org/10.1159/000448179
- Y.-H. Chen, T. Xiao, X.-M. Zheng, Y. Xu, K.-T. Zhuang, W.-J. Wang, X.-M. Chen, Q. Hong and G.-Y. Cai, Local renal treatments for acute kidney injury: A review of current progress and future translational opportunities, J. Endourology 38(5) (2024) 466–479; https://doi.org/10.1089/end.2023.0705
- R. Binato, T. de Souza Fernandez, C. Lazzarotto-Silva, B. Du Rocher, A. Mencalha, L. Pizzatti, L. F. Bouzas and E. Abdelhay, Stability of human mesenchymal stem cells during in vitro culture: considerations for cell therapy, Cell Prolif. 46(1) (2013) 10–22; https://doi.org/10.1111/cpr.12002
- G. Cai, Y. Lu, J. Chen, D. Yang, R. Yan, M. Ren, S. He, S. Wu and Y. Zhao, Brain-wide mapping of c-Fos expression with fluorescence micro-optical sectioning tomography in a chronic sleep deprivation mouse model, Neurobiol. Stress 20 (2022) Article ID 100478 (13 pages); https://doi.org/10.1016/j.ynstr.2022.100478
- A. Mii, A. Shimizu, H. Yamaguchi and S. Tsuruoka, Renal complications after hematopoietic stem cell transplantation: Role of graft-versus-host disease in renal thrombotic microangiopathy, J. Nippon Med. School 87(1) (2020) 7–12; https://doi.org/10.1272/jnms.JNMS.2020_87-102
- H. Zhou, Z. Liu, Y. Wang, X. Wen, E. H. Amador, L. Yuan, X. Ran, L. Xiong, Y. Ran, W. Chen and Y. Wen, Colorectal liver metastasis: molecular mechanism and interventional therapy, Sig. Trans-duct. Target. Ther. 7(1) (2022) Article ID 70 (25 pages); https://doi.org/10.1038/s41392-022-00922-2
- D. Luger, M. J. Lipinski, P. C. Westman, D. K. Glover, J. Dimastromatteo, J. C. Frias, M. T. Albelda, S. Sikora, A. Kharazi and G. Vertelov, Intravenously delivered mesenchymal stem cells: systemic anti-inflammatory effects improve left ventricular dysfunction in acute myocardial infarction and ischemic cardiomyopathy, Circulation Res. 120(10) (2017) 1598–1613; https://doi.org/10.1161/CIRCRESAHA.117.310599
- Y. Wang and Y. Guo, RenalGuard system and conventional hydration for preventing contrast-associated acute kidney injury in patients undergoing cardiac interventional procedures: A systematic review and meta-analysis, Int. J. Cardiology 333 (2021) 83–89; https://doi.org/10.1016/j.ij-card.2021.02.071
- R. H. Lee, A. A. Pulin, M. J. Seo, D. J. Kota, J. Ylostalo, B. L. Larson, L. Semprun-Prieto, P. Delafontaine and D. J. Prockop, Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6, Cell Stem Cell 5(1) (2009) 54–63; https://doi.org/10.1016/j.stem.2009.05.003
- S. Zonta, M. De Martino, G. Bedino, G. Piotti, T. Rampino, M. Gregorini, F. Frassoni, A. Dal Canton, P. Dionigi and M. Alessiani, Which is the most suitable and effective route of administration for mesenchymal stem cell-based immunomodulation therapy in experimental kidney transplantation: Endovenous or arterial?, Transplant. Proc. 42(4) (2010) 1336–1340; https://doi.org/10.1016/j.transproceed.2010.03.081
- T. Freyman, G. Polin, H. Osman, J. Crary, M. Lu, L. Cheng, M. Palasis and R. L. Wilensky, A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction, Eur. Heart J. 27(9) (2006) 1114–1122; https://doi.org/10.1093/eurheartj/ehi818
- D. Lu, Y. Li, L. Wang, J. Chen, A. Mahmood and M. Chopp, Intraarterial administration of marrow stromal cells in a rat model of traumatic brain injury, J. Neurotrauma 18(8) (2001) 813–819; https://doi.org/10.1089/089771501316919175
- P. Walczak, J. Zhang, A. A. Gilad, D. A. Kedziorek, J. Ruiz-Cabello, R. G. Young, M. F. Pittenger, P. C. van Zijl, J. Huang and J. W. Bulte, Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia, Stroke 39(5) (2008) 1569–1574; https://doi.org/10.1161/strokeaha.107.502047
- G. F. Muschler, C. Nakamoto and L. G. Griffith, Engineering principles of clinical cell-based tissue engineering, J. Bone Joint Surgery 86(7) (2004) 1541–1558; https://doi.org/10.2106/00004623-200407000-00029
- Y. K. Chang, M. H. Chen, Y. H. Chiang, Y. F. Chen, W. H. Ma, C. Y. Tseng, B. W. Soong, J. H. Ho and O. K. Lee, Mesenchymal stem cell transplantation ameliorates motor function deterioration of spinocerebellar ataxia by rescuing cerebellar Purkinje cells, J. Biomed. Sci. 18 (2011) Article ID 54 (9 pages); https://doi.org/10.1186/1423-0127-18-54
- I. M. Barbash, P. Chouraqui, J. Baron, M. S. Feinberg, S. Etzion, A. Tessone, L. Miller, E. Guetta, D. Zipori, L. H. Kedes, R. A. Kloner and J. Leor, Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: Feasibility, cell migration, and body distribution, Circulation 108(7) (2003) 863–868; https://doi.org/10.1161/01.Cir.0000084828.50310.6a
- S. M. Devine, A. M. Bartholomew, N. Mahmud, M. Nelson, S. Patil, W. Hardy, C. Sturgeon, T. Hewett, T. Chung, W. Stock, D. Sher, S. Weissman, K. Ferrer, J. Mosca, R. Deans, A. Moseley and R. Hoffman, Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion, Exp. Hematology 29(2) (2001) 244–255; https://doi.org/10.1016/s0301-472x(00)00635-4
- J. Gao, J. E. Dennis, R. F. Muzic, M. Lundberg and A. I. Caplan, The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion, Cells Tissues Organs 169(1) (2001) 12–20; https://doi.org/10.1159/000047856
- S. M. Devine, C. Cobbs, M. Jennings, A. Bartholomew and R. Hoffman, Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates, Blood 101(8) (2003) 2999–3001; https://doi.org/10.1182/blood-2002-06-1830
- J. W. Lee, X. Fang, N. Gupta, V. Serikov and M. A. Matthay, Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung, PNAS 106(38) (2009) 16357–16362; https://doi.org/10.1073/pnas.0907996106
- G. Moll, R. Jitschin, L. von Bahr, I. Rasmusson-Duprez, B. Sundberg, L. Lönnies, G. Elgue, K. Nilsson-Ekdahl, D. Mougiakakos, J. D. Lambris, O. Ringdén, K. Le Blanc and B. Nilsson, Mesenchymal stromal cells engage complement and complement receptor bearing innate effector cells to modulate immune responses, PloS one 6(7) (2011) e21703 (9 pages); https://doi.org/10.1371/journal.pone.0021703
- I. U. Schraufstatter, R. G. Discipio, M. Zhao and S. K. Khaldoyanidi, C3a and C5a are chemotactic factors for human mesenchymal stem cells, which cause prolonged ERK1/2 phosphorylation, J. Immunol. 182(6) (2009) 3827–3836; https://doi.org/10.4049/jimmunol.0803055
- A. I. Caplan and D. Correa, The MSC: an injury drugstore, Cell Stem Cell 9(1) (2011) 11–15; https://doi.org/10.1016/j.stem.2011.06.008
- A. Shabbir, D. Zisa, H. Lin, M. Mastri, G. Roloff, G. Suzuki and T. Lee, Activation of host tissue trophic factors through JAK-STAT3 signaling: A mechanism of mesenchymal stem cell-mediated cardiac repair, Am. J. Physiol. Heart Circul. Physiol. 299(5) (2010) H1428–1438; https://doi.org/10.1152/ajpheart.00488.2010
Language: English
Page range: 1 - 17
Accepted on: Oct 18, 2025
Published on: Mar 25, 2026
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2026 Liang Xiao, Chunlin Liu, Yuqian Wang, Fucheng Xiao, Jiahua Cai, Shoukang Qu, Xiaojuan Xu, Xiaoliang Wang, Yue Liu, Yutao Peng, Jia Liu, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.